Silver Point Capital »

Sarepta Therapeutics shares owned by Silver Point Capital

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Silver Point Capital from 13F filings

Historical chart of Silver Point Capital investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Silver Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Silver Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.4M 278k 19.27

More positions owned by Silver Point Capital

Gulfport Energy Corp Common Shares (GPOR)
Echostar Corp Note 3.875%11/3 (Principal)
Jd.com Note 0.250% 6/0 (Principal)
Studio City Intl Hldgs Spon Ads (MSC)
Ishares Gold Tr Ishares New (IAU)
Echostar Corp Cl A (SATS)
Ishares Tr Russell 2000 Etf (IWM)
PG&E Corporation (PCG)
Diversified Healthcare Tr Com Sh Ben Int (DHC)
Bausch Plus Lomb Corp Common Shares (BLCO)
Pg&e Corp Pfd Conv Ser A (PCG.PX)
Telephone & Data Sys Com New (TDS)
Edison International (EIX)
Frontier Group Hldgs (ULCC)
Southwest Airlines (LUV)

View all positions for Silver Point Capital

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Renaissance Technologies
Two Sigma Investments
D. E. Shaw & Co
UBS Group
Standard Life Aberdeen
Two Sigma Advisers
First Trust Advisors
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Connor, Clark & Lunn Investment Management

View all funds holding Sarepta Therapeutics